Abstract
During puberty and pregnancy, the breast undergoes major restructuring in order to produce a structure that can secrete and eject copious amounts of milk. By analogy to other branched organs such as the lung or the salivary gland, a large increase in surface area of the specialized epithelium is achieved through repeated ramifications of a system of ducts and alveoli arising from the nipple. In the breast, this process culminates in the appearance of thousands of alveoli or acini, saccular outpouchings from the ductal system. This paper focuses on this final stage of proliferation, the formation of alveolar structures and its control by systemic hormones.
Similar content being viewed by others
REFERENCES
C. W. Daniel and G. B. Silberstein (1987). Postnatal development of the rodent mammary gland. In M. C. Neville and C. W. Daniel (eds.), The Mammary Gland, Plenum, New York, pp. 3–31.
S. Nandi (1958). Endocrine control of mammary gland development and function in the C3H/HeCrgl mouse. J.Natl.CancerInst.: 1039–1063.
W. R. Lyons (1958). Hormonal synergism in mammary growth. Proc.R.Soc.Lond.Ser.B: 303–325.
K. M. Scully, A. S. Gleiberman, Lindzey, D. B. Lubahn, K. S. Korach, and M. G. Rosenfeld (1997). Role of estrogen receptor-alphain the anterior pituitary gland. Mol.Endocrinol.11: 674–681.
S. R. Ojeda (1996). Female reproductive function. In J. E. Griffin and S. R. Ojeda (eds.), Textbook of Endocrine Physiology, Oxford University Press, New York, Oxford, pp. 164–200.
Y. N. Ilkbahar, Thordarson, I. G. Camarillo, and F. Talamantes (1999). Differential expression of the growthhormone receptor and growth hormone-binding protein in ep-ithelia and stroma of the mouse mammary gland at various physiological stages. J.Endocrinol.161: 77–87.
P. Cohen and R. G. Rosenfeld (1996). Growth regulation. In J. E. Griffin and S. R. Ojeda (eds.), Textbook of Endocrine Physiology, Oxford University Press, New York, Oxford, pp. 244–259.
P. D. Walden, Ruan, M.Feldman, and D. L. Kleinberg (1998). Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development. Endocrinology 139: 659–662.
O. M. Conneely, D. M. Kettelberger, M. J. Tsai, W. T. Schrader, and B. W. O'Malley (1989). The chicken progesterone receptor A and B isoforms are products of an alternate translation initiation event. J.Biol.Chem.264: 14062–14064.
C. Brisken, Park, Vass, J. P. Lydon, B. W. O'Malley, and R. A. Weinberg (1998). A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc.Natl.Acad.Sci.U.S.A.95: 5076–5081.
R. C. Humphreys, Lydon, B. W. O'Malley, and J. M. Rosen(1997). Mammary gland development is mediated by both stromaland epithelial progesterone receptors. Mol.Endocrinol.11: 801–811.
G. B. Silberstein, Van Horn, Shyamala, and C. W. Daniel (1996). Progesterone receptors in the mouse mammary duct: Distribution and developmental regulation. Cell Growth Differ.7: 945–952.
T. N. Seagroves, J. P. Lydon, R. C. Hovey, B. K. Vonderhaar,and J. M. Rosen (2000). C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammarygland development. Mol.Endocrinol.14: 359–368.
J. Russo, Ao, Grill, and I. H. Russo (1999). Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland [In Process Citation]. Breast Cancer Res.Treat.53: 217–227.
R. B. Clarke, Howell, C. S. Potten, and E. Anderson (1997). Dissociation between steroid receptor expression and cell pro-liferationin the human breast. Cancer Res.57: 4987–4991.
B. Mulac-Jericevic, R. A. Mullinax, F. J. DeMayo, J. P. Lydon, and O. M.Conneely (2000). Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289: 1751–1754.
G. Shyamala, Yang, Silberstein, M. H. Barcellos-Hoff, and E. Dale (1998). Transgenic mice carrying an imbalance in thenative ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc.Natl.Acad.Sci.U.S.A.95: 696–701.
G. Shyamala, Yang, R. D. Cardiff, and E. Dale (2000). Impact of progesterone receptor on cell-fate decisions during mammary gland development. Proc.Natl.Acad.Sci.U.S.A.97: 3044–3049.
N. D. Horseman, Zhao, Montecino-Rodriguez, Tanaka, Nakashima, S. J. Engle, Smith, Markoff, and K. Dorshkind (1997). Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. Embo.J.16: 6926–6935.
C. J. Ormandy, Camus, Barra, Damotte, Lucas, Buteau, Edery, Brousse, Babinet, Binart, and P. A. Kelly (1997). Null mutation of the prolactin receptor gene pro-ducesmultiple reproductive defects in the mouse. Genes Dev.11: 167–178.
N. Binart, Helloco, C. J. Ormandy, Barra, Clement-Lacroix,N. Baran, and P. A. Kelly (2000). Rescue of pre-implantatoryegg development and embryo implantation inprolactin receptor-deficient mice after progesterone administration. Endocrinology 141: 2691–2697.
C. Bole-Feysot, Goffin, Edery, Binart, and P. A. Kelly(1998). Prolactin (PRL) and its receptor: Actions, signal trans-ductionpathways and phenotypes observed in PRL receptorknockout mice. Endocr.Rev.19: 225–268.
C. Brisken, Kaur, T. E. Chavarria, Binart, R. L. Sutherland, R. A. Weinberg, P. A. Kelly, and C. J. Ormandy (1999). Prolactincontrols mammary gland development via direct and indirectmechanisms. Dev.Biol.210: 96–106.
G. J. Lindeman, Wittlin, Lada, M. J. Naylor, Santamaria, J. G. Zhang, Starr, D. J. Hilton, W. S. Alexander, C. J. Ormandy, and J. Visvader (2001). SOCS1 deficiency resultsin accelerated mammary gland development and rescues lacta-tionin prolactin receptor-deficient mice. Genes Dev.15: 1631–1636.
M. I. Gallego, Binart, G. W. Robinson, Okagaki, K. T. Coschigano, Perry, J. J. Kopchick, Oka, P. A. Kelly, and L. Hennighausen (2001). Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev.Biol.229: 163–175.
Y. Zhou, B. C. Xu, H. G. Maheshwari, He, Reed, M. Lozykowski, Okada, Cataldo, Coschigamo, T. E. Wagner, Baumann, and J. J. Kopchick (1997). A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc.Natl.Acad.Sci.U.S.A.94: 13215–13220.
T. A. Jarvinen, Pelto-Huikko, Holli, and J. Isola (2000). Estrogen receptor beta is coexpressed with ER alpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am.J.Pathol.156: 29–35.
G. Pelletier and M. El-Alfy (2000). Immuno cytochemical localization of estrogen receptors alpha and beta in the human reproductive organs. J.Clin.Endocrinol.Metab.85: 4835–4840.
S. Saji, E. V. Jensen, Nilsson, Rylander, Warner, and J. A. Gustafsson (2000). Estrogen receptors alpha and beta in the rodent mammary gland. Proc.Natl.Acad.Sci.U.S.A.97: 337–342.
J. H. Krege, J. B. Hodgin, J. F. Couse, Enmark, Warner, J. F. Mahler, Sar, K. S. Korach, J. A. Gustafsson, and O. Smithies (1998). Generation and reproductive phenotypesof mice lacking estrogen receptor beta. Proc.Natl.Acad.Sci.U.S.A.95: 15677–15682.
D. B. Lubahn, J. S. Moyer, T. S. Golding, J. F. Couse, K. S. Korach,and O. Smithies (1993). Alteration of reproductive function butnot prenatal sexual development after insertional disruption ofthe mouse estrogen receptor gene. Proc.Natl.Acad.Sci.U.S.A.90: 11162–11166.
J. Lindzey, W. C. Wetsel, J. F. Couse, Stoker, Cooper, and K. S. Korach (1998). Effects of castration and chronic steroid treatments on hypothalamic gonadotropin-releasing hormone content and pituitary gonadotropins in male wild-type and estrogen receptor-alpha knockout mice. Endocrinology 139: 4092–4101.
J. F. Couse, D. O. Bunch, Lindzey, D. W. Schomberg, and K. S. Korach (1999). Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-alpha knockout mouse. Endocrinology 140: 5855–5865.
S. Z. Haslam and G. Shyamala (1979). Effect of oestradiolon progesterone receptors in normal mammary glands and its relationship with lactation. Biochem.J.182: 127–131.
Y. Mizoguchi, J. Y. Kim, Enami, and S. Sakai (1997). The regulation of the prolactin receptor gene expression in the mammary gland of early pregnant mouse. Endocr.J.44: 53–58.
W. P. Bocchinfuso, J. K. Lindzey, S. C. Hewitt, J. A. Clark, P. H. Myers, Cooper, and K. S. Korach (2000). Induction of mammarygland development in estrogen receptor-alpha knockout mice. Endocrinology 141: 2982–2994.
R. A. Huseby, M. J. Soares, and F. Talamantes (1985). Ectopic pituitary grafts in mice: Hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas. Endocrinology 116: 1440–1448.
G. R. Cunha, Young, Y. K. Hom, P. S. Cooke, J. A. Taylor, and D. B. Lubahn (1997). Elucidation of a role for stromalsteroid hormone receptors in mammary gland growth and develop mentusing tissue recombinants. J.Mammary Gland.Biol.Neoplasia 2: 393–402.
T. J. Cole, J. A. Blendy, A. P. Monaghan, Krieglstein, Schmid, Aguzzi, Fantuzzi, Hummler, Unsicker, and G. Schutz (1995). Targeted disruption of the glucocorti-coidreceptor gene blocks adrenergic chromaffin cell devel-opmentand severely retards lung maturation. Genes Dev.9: 1608–1621.
X. Liu, G. W. Robinson, K. U. Wagner, Garrett, Wynshaw-Boris, and L. Hennighausen (1997). Stat5a is mandatory for adult mammary gland development and lacto genesis. GenesDev.11: 179–186.
D. Jackson, Bresnick, Rosewell, Crafton, Poulsom, Stamp, and C. Dickson (1997). Fibroblast growth factor receptor signalling has a role in lobuloalveolar development of the mammary gland. J.Cell.Sci.110: 1261–1268.
D. L. Lacey, Timms, H. L. Tan, M. J. Kelley, C. R. Dunstan,T. Burgess, Elliott, Colombero, Elliott, Scully, Hsu, Sullivan, Hawkins, Davy, Capparelli, Eli, Y. X. Qian, Kaufman, Sarosi, Shalhoub, Senaldi,J. Guo, Delaney, and W. J. Boyle (1998). Osteoprotegerinligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165–176.
J. E. Fata, Y. Y. Kong, Li, Sasaki, Irie-Sasaki, R. A. Moorehead, Elliott, Scully, E. B. Voura, D. L. Lacey, W. J. Boyle, Khokha, and J. M. Penninger (2000). The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103: 41–50.
M. A. Thiede (1989). The mRNA encoding a parathyroid hormone-like peptide is produced in mammary tissue in re-sponseto elevations in serum prolactin. Mol.Endocrinol.3: 1443–1447.
M. E. Dunbar and J. J. Wysolmerski (1999). Parathyroid hormone-related protein: A developmental regulatory molecule necessary for mammary gland development. J.Mammary Gland Biol.Neoplasia 4: 21–34.
J. Russo and I. H. Russo (1987). Development of the humanmammary gland. In M. C. Neville and C. W. Daniel (eds.), TheMammary Gland, Plenum, New York, pp. 67–93.
S. R. Wellings and H. M. Jensen (1973). On the origin and progression of ductal carcinoma in the human breast. J.Natl.Cancer Inst.50: 1111–1118.
J. R. Harris, M. E. Lippman, Veronesi, and W. Willett (1992). Breast cancer (1). N.Engl.J.Med.327: 319–328.
J. S. Meyer (1977). Cell proliferation in normal human breastducts, fibroadenomas, and other ductal hyperplasias measuredby nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones. Hum.Pathol.8: 67–81.
J. E. Fata, Chaudhary, and R. Khokha (2001). Cellular turnover in the mammary gland is correlated with systemic levels of progesterone and not 17beta-estradiol during the estrouscycle. Biol.Reprod.65: 680–688.
R. C. Moon (1969). Relationship between previous reproductive history and chemically induced mammary cancer in rats. Int.J.Cancer 4: 312–317.
D. Medina, L. E. Peterson, Moraes, and J. Gay (2001). Short-term exposure to estrogen and progesterone induces partial protection against N-nitroso-N-methylurea-induced mammary tumori genesis in Wistar-Furth rats. Cancer Lett.169: 1–6.
J. P. Lydon, F. J. DeMayo, C. R. Funk, S. K. Mani, A. R. Hughes, C. A. Montgomery Jr., Shyamala, O. M. Conneely, and B. W. O'Malley (1995). Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev.15: 2266–2278.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brisken, C. Hormonal Control of Alveolar Development and Its Implications for Breast Carcinogenesis. J Mammary Gland Biol Neoplasia 7, 39–48 (2002). https://doi.org/10.1023/A:1015718406329
Issue Date:
DOI: https://doi.org/10.1023/A:1015718406329